Skip to main content
. 2011 Oct 18;7:611–620. doi: 10.2147/NDT.S14385

Table 1.

Cochrane risperidone reviews

Review Sample/studies For risperidone Against risperidone
Rattehalli et al9
Risperidone vs placebo for schizophrenia
n = 1363, 10 RCTs Greater reduction in PANNS/BPRS scores
Less number of risperidone subjects left the trial owing to lack of efficacy
More EPSE but did not reach statistical significance
Prolactin elevation
Hunter et al11
Risperidone vs typical antipsychotic medication for schizophrenia
n = 2368, 9 RCTs Better outcomes in both short and long term trials
Reduction in relapse rate
Less extrapyramidal side effects
Weight gain
Prolactin elevation and sexual side effects were comparable to haloperidol
Komossa et al14
Risperidone vs other atypical antipsychotics
n = 7760, 45 RCTs Better PANNS score reduction than quetiapine and ziprasidone
Better than ziprasidone in leaving study due to inefficacy
Equal efficacy compared to aripiprazole and amisulpride
Olanzapine better on PANNS reduction
Olanzapine and clozapine better than risperidone in leaving study due to inefficacy EPSE
Prolactin elevation

Abbreviations: RCT, randomized controlled trial; PANNS, positive and negative syndrome scale; BPRS, brief psychiatric scale; EPSE, extra pyramidal side effects.